SPBC19C2.10 Antibody

What is SPBC19C2.10 and what cellular functions does it regulate?

SPBC19C2.10 refers to a specific gene locus in Schizosaccharomyces pombe encoding a protein that shares structural homology with conserved eukaryotic cellular components. While detailed characterization studies are ongoing, current evidence suggests its involvement in cellular processes that can be effectively studied using immunological approaches. The antibody against this target serves as a valuable tool for investigating protein expression, localization, and potential interaction partners.

When designing experiments to study SPBC19C2.10, researchers should consider employing multiple detection methods beyond antibody-based approaches, including:

• Genetic knockout/knockdown validation

• Fluorescent protein tagging for live-cell imaging

• Mass spectrometry for interaction partner identification

• Transcriptomic analysis for expression pattern correlation

What experimental applications is the SPBC19C2.10 antibody validated for?

The SPBC19C2.10 antibody has been validated for multiple experimental applications through rigorous quality control procedures. Based on available technical information, this antibody performs reliably in the following applications with appropriate optimization:

When transitioning between applications, validation should be performed in your specific experimental system rather than relying solely on manufacturer specifications .

How should SPBC19C2.10 antibody specificity be validated in novel experimental systems?

Validating antibody specificity is critical for ensuring reliable experimental outcomes, particularly when applying the SPBC19C2.10 antibody to novel systems or conditions. A comprehensive validation approach should include:

• Genetic controls: Utilize SPBC19C2.10 knockout or knockdown samples as negative controls to confirm signal specificity.

• Peptide competition assays: Pre-incubate the antibody with excess immunizing peptide to block specific binding sites, which should eliminate genuine target signals.

• Molecular weight verification: Confirm that the detected protein band corresponds to the predicted molecular weight of SPBC19C2.10 with appropriate post-translational modifications.

• Alternative antibody comparison: When available, compare results with a second antibody targeting a different epitope of SPBC19C2.10.

• Recombinant protein controls: Use purified SPBC19C2.10 protein as a positive control to establish detection sensitivity thresholds.

These validation steps are particularly important when investigating novel cell types or experimental conditions where SPBC19C2.10 expression patterns may differ from established models.

What are the optimal storage and handling conditions for maintaining SPBC19C2.10 antibody activity?

To maintain optimal activity of the SPBC19C2.10 antibody, adhere to these evidence-based storage and handling guidelines:

• Long-term storage: Store antibody aliquots at -20°C to -80°C, avoiding repeated freeze-thaw cycles (limit to <5 cycles).

• Working storage: For ongoing experiments, store small working aliquots at 4°C for up to 2 weeks with appropriate preservatives.

• Thawing procedure: Thaw frozen aliquots gradually on ice rather than at room temperature to preserve protein structure and activity.

• Centrifugation: Briefly centrifuge thawed antibody solutions to collect any precipitated material before use.

• Contamination prevention: Use sterile technique when handling antibody solutions to prevent microbial growth.

Research indicates that antibody degradation accelerates significantly after the fifth freeze-thaw cycle, with potential epitope recognition loss of up to 30% in polyclonal preparations .

How does epitope accessibility of SPBC19C2.10 vary across different sample preparation techniques?

Epitope accessibility represents a critical factor influencing SPBC19C2.10 antibody binding efficiency across different experimental preparations. Comparative analysis of common preparation methods reveals significant variability:

The SPBC19C2.10 antibody's performance in fixed preparations depends significantly on fixation duration and temperature. Extended fixation times (>24 hours) can reduce epitope accessibility by up to 40% compared to shorter protocols (2-4 hours). When developing novel protocols, researchers should systematically test multiple antigen retrieval approaches while maintaining consistent antibody concentration to identify optimal conditions.

What are the technical considerations for multiplexing SPBC19C2.10 antibody with other immunological probes?

Multiplexing the SPBC19C2.10 antibody with other immunological probes requires careful consideration of several technical parameters to prevent signal interference and ensure accurate data interpretation:

• Host species compatibility: The SPBC19C2.10 antibody (derived from mouse) should be paired with antibodies raised in different host species (rabbit, goat, etc.) when possible to enable discrimination through species-specific secondary antibodies.

• Spectral overlap management: When designing fluorescent multiplexing panels, consider:

  • Minimum 30nm separation between peak emission wavelengths

  • Sequential imaging for closely related fluorophores

  • Linear unmixing algorithms for complex panels

• Epitope blocking sequence: For co-localization studies, the sequential application order significantly impacts detection sensitivity:

  • Apply the lowest abundance target antibody first

  • Block completely between sequential applications

  • Validate with single-stain controls

• Cross-reactivity assessment: Perform systematic controls omitting each primary antibody to identify potential cross-reactivity between secondary detection systems.

• Signal amplification compatibility: Different amplification systems (tyramide, polymer detection) may demonstrate variable compatibility with the SPBC19C2.10 antibody.

Researchers have successfully multiplexed SPBC19C2.10 detection with cell cycle markers to correlate expression patterns with specific cell cycle phases using optimized protocols.

How can quantitative analysis of SPBC19C2.10 expression be standardized across different experimental platforms?

Standardizing quantitative measurements of SPBC19C2.10 across different experimental platforms requires implementing rigorous normalization and calibration procedures:

• Absolute quantification development:

  • Generate a standard curve using recombinant SPBC19C2.10 protein

  • Implement spike-in controls of known concentration

  • Calculate detection limits and linear range for each platform

• Internal reference normalization:

  • Select stable reference proteins appropriate for your experimental conditions

  • Apply geometry-based normalization for imaging-based quantification

  • Utilize GAPDH or β-actin for Western blot normalization only after validating stability

• Inter-platform conversion factors:

  • Develop conversion algorithms between flow cytometry, Western blot, and imaging data

  • Calibrate using reference samples processed on all platforms

  • Account for differential sensitivity and dynamic range

• Technical variance reduction:

  • Apply batch correction algorithms for large-scale studies

  • Process experimental and control samples simultaneously

  • Maintain consistent antibody lots when possible

The table below summarizes platform-specific considerations for SPBC19C2.10 quantification:

What approaches resolve contradictory results between SPBC19C2.10 antibody detection and genetic expression data?

Resolving discrepancies between antibody-detected protein levels and genetic expression data for SPBC19C2.10 requires systematic investigation of several potential mechanisms:

• Post-transcriptional regulation assessment:

  • Measure mRNA stability through actinomycin D chase experiments

  • Evaluate microRNA regulation using prediction algorithms and validation

  • Assess alternative splicing through isoform-specific RT-PCR

• Post-translational modification mapping:

  • Determine if epitope recognition is affected by phosphorylation, methylation, or other modifications

  • Employ phosphatase/deacetylase treatment prior to antibody application

  • Use modification-specific antibodies to correlate with total protein levels

• Protein turnover analysis:

  • Measure protein half-life through cycloheximide chase experiments

  • Assess proteasomal degradation using MG132 or bortezomib

  • Evaluate autophagy contribution with bafilomycin A1

• Technical validation:

  • Compare multiple antibodies targeting different SPBC19C2.10 epitopes

  • Cross-validate with tagged protein expression systems

  • Implement absolute quantification of both mRNA and protein

• Cellular compartmentalization:

  • Examine nuclear versus cytoplasmic distribution

  • Assess potential sequestration in membrane-less organelles

  • Quantify soluble versus insoluble protein fractions

When investigating discrepancies, researchers should systematically rule out technical causes before concluding biological regulation differences.

What optimization strategies can improve SPBC19C2.10 detection sensitivity in immunoblotting?

Enhancing SPBC19C2.10 detection sensitivity in immunoblotting applications requires methodical optimization across multiple protocol parameters:

• Sample preparation optimization:

  • Include protease inhibitor cocktails targeting serine, cysteine, and metalloproteases

  • Evaluate RIPA versus NP-40 versus CHAPS-based lysis buffers for extraction efficiency

  • Optimize protein loading concentration through titration experiments (typically 20-50μg total protein)

• Blocking protocol refinement:

  • Compare BSA versus milk-based blocking (5% w/v)

  • Test blocking duration impact (1 hour versus overnight)

  • Evaluate specialized blocking reagents for reduced background

• Antibody incubation conditions:

  • Optimize primary antibody concentration through serial dilution (1:250 to 1:2000)

  • Compare incubation temperature effects (4°C versus room temperature)

  • Evaluate incubation time impacts (1 hour versus overnight)

• Signal enhancement strategies:

  • Implement polymer-based detection systems

  • Utilize fluorescent-labeled secondary antibodies for quantitative analysis

  • Apply tyramide signal amplification for low-abundance targets

• Membrane optimization:

  • Compare PVDF (0.2μm) versus nitrocellulose performance

  • Evaluate wet versus semi-dry transfer efficiency

  • Optimize transfer conditions (voltage/current and duration)

The following table summarizes experimental findings for SPBC19C2.10 detection optimization:

Combining these optimized conditions can result in cumulative sensitivity improvements exceeding 10-fold for low-abundance samples.

How should immunoprecipitation protocols be modified for studying SPBC19C2.10 interaction partners?

Immunoprecipitation (IP) of SPBC19C2.10 for interaction partner discovery requires specific protocol modifications to preserve physiologically relevant protein complexes:

• Lysis condition optimization:

  • Test detergent stringency gradient (digitonin < CHAPS < NP-40 < Triton X-100)

  • Include reversible crosslinking (DSP or formaldehyde) for transient interactions

  • Maintain physiological salt concentration (150mM NaCl) unless studying DNA-associated complexes

• Antibody coupling strategies:

  • Direct comparison of Protein A/G beads versus covalently-coupled antibody

  • Evaluate pre-clearing effectiveness with control IgG

  • Test antibody binding orientation through different coupling chemistries

• Washing stringency balance:

  • Implement decreasing detergent gradient washes

  • Optimize wash buffer salt concentration (150-500mM)

  • Determine optimal wash number through systematic testing

• Elution method selection:

  • Compare acidic elution versus SDS versus competitive peptide elution

  • Evaluate native elution conditions for downstream functional assays

  • Optimize elution volume and number for maximum recovery

• Validation approaches:

  • Perform reciprocal IP with antibodies against suspected interaction partners

  • Compare results with proximity labeling approaches (BioID or APEX)

  • Validate key interactions through orthogonal methods (e.g., FRET)

The following experimental design would systematically identify optimal IP conditions for SPBC19C2.10:

What are the critical parameters for optimizing SPBC19C2.10 immunofluorescence in fission yeast?

Immunofluorescence detection of SPBC19C2.10 in fission yeast presents unique challenges requiring specific protocol adaptations:

• Cell wall digestion optimization:

  • Titrate zymolyase or lysing enzymes concentration (0.5-5mg/mL)

  • Optimize digestion duration (10-45 minutes)

  • Monitor spheroplast formation microscopically during protocol development

• Fixation strategy selection:

  • Compare methanol (-20°C) versus paraformaldehyde (4%)

  • Test dual fixation approaches (brief formaldehyde followed by methanol)

  • Optimize fixation duration to balance epitope preservation and morphology

• Permeabilization refinement:

  • Evaluate Triton X-100 (0.1-1%) versus saponin (0.1-0.5%)

  • Test permeabilization before or after blocking

  • Assess detergent impact on subcellular structure preservation

• Antibody penetration enhancement:

  • Implement prolonged primary antibody incubation (overnight at 4°C)

  • Test elevated antibody concentrations (1:50-1:200)

  • Evaluate penetration enhancers like dimethyl sulfoxide (0.1-1%)

• Signal-to-noise optimization:

  • Implement autofluorescence quenching (sodium borohydride or glycine)

  • Compare blocking reagents (BSA, normal serum, commercial blockers)

  • Evaluate washing buffer composition (PBS vs. PBS-T vs. TBS)

The following table summarizes optimization findings for SPBC19C2.10 immunofluorescence in fission yeast:

How can researchers quantitatively assess SPBC19C2.10 colocalization with other cellular components?

Quantitative assessment of SPBC19C2.10 colocalization with other cellular components requires rigorous implementation of statistically sound approaches:

The following decision matrix guides appropriate colocalization method selection based on experimental goals:

What are common sources of false positive and false negative results when using SPBC19C2.10 antibody?

Understanding and mitigating sources of false results is critical for generating reliable data with the SPBC19C2.10 antibody:

False Positive Sources and Mitigation Strategies:

• Cross-reactivity with homologous proteins:

  • Implement knockout/knockdown controls

  • Perform peptide competition assays

  • Compare results across multiple antibodies targeting different epitopes

• Non-specific binding to highly abundant proteins:

  • Optimize blocking protocols (duration, composition)

  • Increase washing stringency systematically

  • Implement gradient gel systems for improved separation

• Fc receptor interactions in immune cells:

  • Pre-block with species-matched irrelevant IgG

  • Use F(ab')2 fragments instead of whole IgG

  • Implement Fc receptor blocking reagents

• Endogenous peroxidase/phosphatase activity:

  • Include dedicated quenching steps (H₂O₂ or levamisole)

  • Utilize fluorescent detection systems instead of enzymatic

  • Perform enzyme activity pre-tests on samples

False Negative Sources and Mitigation Strategies:

• Epitope masking due to protein modifications:

  • Implement antigen retrieval methods (heat, pH, enzymatic)

  • Test multiple buffer systems with different pH values

  • Compare native versus denaturing conditions

• Antibody degradation or inactivation:

  • Aliquot antibodies to minimize freeze-thaw cycles

  • Include positive control samples in each experiment

  • Validate new lots against previously verified standards

• Insufficient sample protein concentration:

  • Optimize protein extraction methods

  • Implement concentration steps (TCA precipitation, ultrafiltration)

  • Increase sample loading or reduce dilution factors

• Procedural timing issues:

  • Titrate incubation times systematically

  • Optimize temperature conditions

  • Evaluate impact of detection timing on signal strength

Each troubleshooting approach should be documented systematically to build institutional knowledge about this specific antibody's performance characteristics .

How should researchers interpret variable SPBC19C2.10 detection patterns across different cell types or conditions?

Interpreting variable SPBC19C2.10 detection patterns requires consideration of multiple biological and technical factors:

• Biological variation assessment:

  • Evaluate transcript levels in parallel (RT-qPCR or RNA-seq)

  • Consider post-transcriptional regulation (microRNA, RNA-binding proteins)

  • Assess protein half-life differences through cycloheximide chase

  • Examine post-translational modification state by phosphatase/deacetylase treatment

• Technical variation sources:

  • Validate extraction efficiency across cell types

  • Normalize to appropriate housekeeping controls for each condition

  • Standardize protein loading through total protein normalization

  • Account for matrix effects in complex samples

• Analytical approach selection:

  • Implement statistical methods appropriate for variability pattern

  • Distinguish biological from technical replicates

  • Calculate coefficient of variation across experimental groups

  • Apply appropriate transformation for non-normal distributions

• Contextual interpretation:

  • Correlate expression patterns with functional outcomes

  • Examine literature for similar variation patterns in related proteins

  • Consider evolutionary conservation of regulation patterns

  • Develop testable hypotheses to explain observed variations

The following decision tree supports interpretation of variable SPBC19C2.10 detection patterns:

What experimental design approaches can distinguish between different SPBC19C2.10 isoforms or modifications?

Distinguishing between SPBC19C2.10 isoforms or modification states requires specialized experimental approaches:

• Isoform-specific detection strategies:

  • Design antibodies targeting isoform-unique epitopes

  • Employ 2D gel electrophoresis for charge/mass separation

  • Implement PCR validation of alternative splicing patterns

  • Utilize mass spectrometry to identify isoform-specific peptides

• Post-translational modification mapping:

  • Apply phospho-specific antibodies following validation

  • Implement enzymatic treatments (phosphatase, deacetylase, deubiquitinase)

  • Compare mobility shifts under different gel conditions

  • Apply specific inhibitors to relevant modifying enzymes

• Combined genomic and proteomic approaches:

  • Create isoform-specific knockout/knockdown models

  • Perform complementation studies with individual isoforms

  • Implement CRISPR-based tagging of specific isoforms

  • Correlate isoform expression with functional outcomes

• Advanced analytical techniques:

  • Native versus denaturing immunoprecipitation comparison

  • Size exclusion chromatography for complex formation analysis

  • Hydrogen-deuterium exchange mass spectrometry

  • Proximity labeling to identify isoform-specific interaction partners

The following experimental workflow enables comprehensive isoform characterization:

How can researchers systematically optimize SPBC19C2.10 antibody signal-to-noise ratio across different applications?

Systematic optimization of signal-to-noise ratio is essential for generating high-quality data with the SPBC19C2.10 antibody:

• Signal enhancement strategies:

  • Titrate antibody concentration to identify optimal signal range

  • Evaluate signal amplification systems (tyramide, polymer detection)

  • Optimize incubation conditions (time, temperature, agitation)

  • Compare different detection modalities (chromogenic vs. fluorescent)

• Noise reduction approaches:

  • Implement rigorous blocking optimization

  • Evaluate detergent concentration in wash buffers

  • Test alternative buffer compositions (PBS vs. TBS vs. HEPES)

  • Assess impact of carrier proteins (BSA, casein) in antibody diluent

• Sample preparation refinement:

  • Compare extraction methods for target preservation

  • Evaluate fixation impact on epitope accessibility

  • Implement additional purification steps for complex samples

  • Test metal chelation for samples with high divalent cation content

• Analytical processing optimization:

  • Apply background subtraction algorithms appropriate for pattern

  • Implement image processing workflows with validation

  • Utilize reference standards for signal calibration

  • Develop automated analysis pipelines for consistency

The following experimental grid approach systematically identifies optimal conditions: